PRINCETON, N.J., February 10, 2025--Bristol Myers Squibb Announces Positive Topline Results for Breyanzi in Adult Patients with Relapsed or Refractory Marginal Zone Lymphoma ...
Bristol-Myers Squibb was founded in 1858 and has grown to be one of today's leading global pharmaceutical companies. For over 150 years, Bristol-Myers Squibb (BMS) has been committed to "discover ...
Adding talazoparib (Talzenna) to enzalutamide (Xtandi) as initial treatment for metastatic castration-resistant prostate ...
Sanofi and Bristol-Myers Squibb have announced they are restructuring their successful long-term alliance. This announcement follows the loss of exclusivity of two key drugs, blood thinner Plavix ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
With positive mid-stage results in marginal zone lymphoma, Bristol Myers Squibb could soon add a new indication for the CAR T ...
Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and broad Medicaid/Medicare coverage, supporting its blockbuster potential in schizophrenia and future label expansions.
StockStory.org on MSN2 天
Earnings To Watch: Zoetis (ZTS) Reports Q4 Results TomorrowDetailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.
Here’s what you need to know ahead of the 97th Academy Awards - The Oscars are taking place in March. Here’s what you need to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果